10x Genomics EBITDA 2018-2024 | TXG

10x Genomics ebitda from 2018 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
10x Genomics Annual EBITDA
(Millions of US $)
2023 $-222
2022 $-135
2021 $-24
2020 $-515
2019 $-24
2018 $-107
2017 $-14
10x Genomics Quarterly EBITDA
(Millions of US $)
2024-03-31 $-50
2023-12-31 $-43
2023-09-30 $-83
2023-06-30 $-51
2023-03-31 $-43
2022-12-31 $-15
2022-09-30 $-32
2022-06-30 $-55
2022-03-31 $-34
2021-12-31 $-9
2021-09-30 $-9
2021-06-30 $-3
2021-03-31 $-4
2020-12-31 $-404
2020-09-30 $-60
2020-06-30 $-35
2020-03-31 $-16
2019-12-31 $-5
2019-09-30 $-7
2019-06-30 $-9
2019-03-31 $-2
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.208B $0.619B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.723B 19.61
Inspire Medical Systems (INSP) United States $7.393B 0.00
IRhythm Technologies (IRTC) United States $3.477B 0.00
Axonics (AXNX) United States $3.412B 0.00
Enovis (ENOV) United States $3.038B 23.08
Azenta (AZTA) United States $2.905B 236.82
Olink Holding AB (publ) (OLK) Sweden $2.820B 0.00
Hims & Hers Health (HIMS) United States $2.680B 0.00
Privia Health (PRVA) United States $2.139B 94.89
Schrodinger (SDGR) United States $1.827B 0.00
Omnicell (OMCL) United States $1.248B 30.53
Phreesia (PHR) United States $1.185B 0.00
Definitive Healthcare (DH) United States $0.821B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.680B 0.00
Fulgent Genetics (FLGT) United States $0.619B 0.00
Talkspace (TALK) United States $0.536B 0.00
Health Catalyst (HCAT) United States $0.373B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.329B 0.00
Clover Health Investments (CLOV) United States $0.318B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
P3 Health Partners (PIII) United States $0.183B 0.00
Butterfly Network (BFLY) United States $0.164B 0.00
American Well (AMWL) United States $0.154B 0.00
Outset Medical (OM) United States $0.147B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
Augmedix (AUGX) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.04
111 (YI) China $0.088B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.048B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.025B 0.00
Cue Health (HLTH) United States $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00